2-147920330-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_001616.5(ACVR2A):c.1063G>A(p.Asp355Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000617 in 1,459,814 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000062 ( 0 hom. )
Consequence
ACVR2A
NM_001616.5 missense
NM_001616.5 missense
Scores
5
4
10
Clinical Significance
Conservation
PhyloP100: 10.0
Genes affected
ACVR2A (HGNC:173): (activin A receptor type 2A) This gene encodes a receptor that mediates the functions of activins, which are members of the transforming growth factor-beta (TGF-beta) superfamily involved in diverse biological processes. The encoded protein is a transmembrane serine-threonine kinase receptor which mediates signaling by forming heterodimeric complexes with various combinations of type I and type II receptors and ligands in a cell-specific manner. The encoded type II receptor is primarily involved in ligand-binding and includes an extracellular ligand-binding domain, a transmembrane domain and a cytoplasmic serine-threonine kinase domain. This gene may be associated with susceptibility to preeclampsia, a pregnancy-related disease which can result in maternal and fetal morbidity and mortality. Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jun 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAdExome4 at 9 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACVR2A | NM_001616.5 | c.1063G>A | p.Asp355Asn | missense_variant | 8/11 | ENST00000241416.12 | NP_001607.1 | |
ACVR2A | NM_001278579.2 | c.1063G>A | p.Asp355Asn | missense_variant | 9/12 | NP_001265508.1 | ||
ACVR2A | NM_001278580.2 | c.739G>A | p.Asp247Asn | missense_variant | 8/11 | NP_001265509.1 | ||
ACVR2A | XM_047446292.1 | c.739G>A | p.Asp247Asn | missense_variant | 8/11 | XP_047302248.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACVR2A | ENST00000241416.12 | c.1063G>A | p.Asp355Asn | missense_variant | 8/11 | 1 | NM_001616.5 | ENSP00000241416.7 | ||
ACVR2A | ENST00000404590.1 | c.1063G>A | p.Asp355Asn | missense_variant | 9/12 | 1 | ENSP00000384338.1 | |||
ACVR2A | ENST00000535787.5 | c.739G>A | p.Asp247Asn | missense_variant | 8/11 | 2 | ENSP00000439988.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250468Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135350
GnomAD3 exomes
AF:
AC:
1
AN:
250468
Hom.:
AF XY:
AC XY:
0
AN XY:
135350
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000617 AC: 9AN: 1459814Hom.: 0 Cov.: 29 AF XY: 0.00000964 AC XY: 7AN XY: 726334
GnomAD4 exome
AF:
AC:
9
AN:
1459814
Hom.:
Cov.:
29
AF XY:
AC XY:
7
AN XY:
726334
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 13, 2024 | The c.1063G>A (p.D355N) alteration is located in exon 8 (coding exon 8) of the ACVR2A gene. This alteration results from a G to A substitution at nucleotide position 1063, causing the aspartic acid (D) at amino acid position 355 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
.;D;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;L
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D;D
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
D;.;D
Vest4
MutPred
Loss of phosphorylation at T356 (P = 0.1413);.;Loss of phosphorylation at T356 (P = 0.1413);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at